🔎 Trials Near Me

Hjem › Geografisk atrofi › North Carolina

Geografisk atrofi kliniske forsøg i North Carolina

7 studier for Geografisk atrofi søger deltagere på steder i North Carolina.

Byer i North Carolina

Officiel studietekst (engelsk)

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  • Asheville Eye Associates - Western Carolina Retinal Associates, Asheville
  • Duke Eye Center, Durham
  • Graystone Eye, Hickory
  • og 1 flere
RekruttererFase 2/3
Alder 60 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT06635148

A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

  • North Carolina (Nc) Retina Associates - Wake Forest Office- Site Number : 8400059, Wake Forest
RekruttererFase 1/2
Alder 60 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07215234

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

  • NC Retina Associates, Cary
  • Graystone Eye, Hickory
  • North Carolina Retina Associates, Wake Forest
  • og 1 flere
RekruttererFase 3
Alder 50 til 85 · Alle køn · Opdateret 18. sep. 2026 · NCT06541704

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

  • North Carolina Retina Associates, Cary
  • Duke Eye Center, Durham
  • North Carolina Retina Associates, Greenville
  • og 1 flere
RekruttererFase 2
Alder 55 og opefter · Alle køn · Opdateret 10. sep. 2026 · NCT06659445

A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)

  • Duke Eye Center, Durham
RekruttererObservationsstudie
Alder 55 og opefter · Alle køn · Opdateret 3. sep. 2026 · NCT07144137

Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD

  • Western Carolina Retinal Associates, Asheville
Rekrutterer
Alder 65 og opefter · Alle køn · Opdateret 3. dec. 2024 · NCT05438732

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.